Intellia Therapeutics, Inc. - COM (NTLA)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM
Number of holders
286
Total Shares
78.2M
Shares change
-439K
Total reported value, excl. options
$3.19B
Value change
-$9.36M
Put/Call ratio
1.94
Number of buys
136
Number of sells
-106
Price
$40.78
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.